11161256

Source:http://linkedlifedata.com/resource/pubmed/id/11161256

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0079613, umls-concept:C0920434, umls-concept:C1321872, umls-concept:C1516698
pubmed:issue	1
pubmed:dateCreated	2001-2-22
pubmed:abstractText	MNCs for adoptive immunotherapy may be collected by leukocytapheresis with a cell separator.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0417360
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0041-1132
pubmed:author	pubmed-author:EcksteinRR, pubmed-author:FeuersteinBB, pubmed-author:GlaserAA, pubmed-author:Schuler-ThurnerBB, pubmed-author:WeisbachVV, pubmed-author:ZimmermannRR, pubmed-author:ZingsemJJ
pubmed:issnType	Print
pubmed:volume	41
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	117-22
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11161256-Adult, pubmed-meshheading:11161256-Aged, pubmed-meshheading:11161256-Blood Platelets, pubmed-meshheading:11161256-Cell Separation, pubmed-meshheading:11161256-Cytapheresis, pubmed-meshheading:11161256-Female, pubmed-meshheading:11161256-Humans, pubmed-meshheading:11161256-Immunotherapy, Adoptive, pubmed-meshheading:11161256-Male, pubmed-meshheading:11161256-Melanoma, pubmed-meshheading:11161256-Middle Aged, pubmed-meshheading:11161256-Monocytes, pubmed-meshheading:11161256-Neoplasm Staging, pubmed-meshheading:11161256-Software, pubmed-meshheading:11161256-Specimen Handling
pubmed:year	2001
pubmed:articleTitle	Collection of MNCs with two cell separators for adoptive immunotherapy in patients with stage IV melanoma.
pubmed:affiliation	Department of Transfusion Medicine and Haemostaseology, University of Erlangen-NYrnberg, Erlangen, Germany. reinhold.eckstein@trans.imed.uni-erlangen.de
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I